Live feed
Filing
SC 13D/A
SC 13D/A0000947871-20-000795·Eledon Pharmaceuticals, Inc.
Schedule 13D ownership disclosure
Tokai Pharmaceuticals Inc
Security class unavailable · CUSIP: 67011N204
Event date: 2020-10-05
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 14.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-20-000795
- Form type
- SC 13D/A
- Filer
- Eledon Pharmaceuticals, Inc.
- CIK
- CIK 1404281
- Filed
- Oct 14, 2020
- Reporting period
- Oct 05, 2020
- Description
- Schedule 13D beneficial ownership